Previously treated cases tested for RR-/MDR-TB in Americas (WHO region)
Americas (WHO region): Previously treated cases tested for RR-/MDR-TB was 78.0% in 2024. ◆ Volatile
Previously treated cases tested for RR-/MDR-TB in Americas (WHO region), 2005–2024
Source: World Health Organization, Global Health Observatory.
Analysis
In 2024, previously treated cases tested for rr-/mdr-tb in Americas (WHO region) stood at 78.0%. That is the highest value across all 20 years on record.
Compared with earlier readings it is up 6.8% on the previous year and up 136.4% over ten years.
Over the whole period, previously treated cases tested for rr-/mdr-tb in Americas (WHO region) peaked at 78.0% in 2024 and was at its lowest, 11.0%, in 2006.
The series is highly variable year to year, so single readings are best treated with caution.
Previously treated cases tested for RR-/MDR-TB in Americas (WHO region), year by year
| Year | Value | Change |
|---|---|---|
| 2005 | 49.0% | — |
| 2006 | 11.0% | -77.6% |
| 2007 | 19.0% | +72.7% |
| 2008 | 19.0% | +0.0% |
| 2009 | 14.0% | -26.3% |
| 2010 | 19.0% | +35.7% |
| 2011 | 22.0% | +15.8% |
| 2012 | 23.0% | +4.5% |
| 2013 | 28.0% | +21.7% |
| 2014 | 33.0% | +17.9% |
| 2015 | 46.0% | +39.4% |
| 2016 | 40.0% | -13.0% |
| 2017 | 47.0% | +17.5% |
| 2018 | 52.0% | +10.6% |
| 2019 | 56.0% | +7.7% |
| 2020 | 60.0% | +7.1% |
| 2021 | 68.0% | +13.3% |
| 2022 | 68.0% | +0.0% |
| 2023 | 73.0% | +7.4% |
| 2024 | 78.0% | +6.8% |
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2000s | 22.4% | 11.0% | 49.0% | 5 |
| 2010s | 36.6% | 19.0% | 56.0% | 10 |
| 2020s | 69.4% | 60.0% | 78.0% | 5 |
More health data for Americas (WHO region)
- Pertussis - number of reported cases, gaps filled 24,640 (2025)
- Diphtheria - number of reported cases, gaps filled 72 (2025)
- Measles - number of reported cases, gaps filled 12,380 (2025)
- Total tetanus - number of reported cases, gaps filled 385 (2025)
- Measles - number of reported cases, annual growth rate 22.22 % change on previous year (2024)
- Pertussis - number of reported cases, annual growth rate -20.67 % change on previous year (2025)
- Total tetanus - number of reported cases, annual growth rate -12.7 % change on previous year (2025)
- Total tetanus - number of reported cases 385 (2025)
- Pertussis - number of reported cases 24,640 (2025)
- Diphtheria - number of reported cases 72 (2025)
Frequently asked questions
- What is previously treated cases tested for rr-/mdr-tb in Americas (WHO region)?
- Previously treated cases tested for rr-/mdr-tb in Americas (WHO region) was 78.0% in 2024, according to World Health Organization, Global Health Observatory.
- What is the highest previously treated cases tested for rr-/mdr-tb recorded in Americas (WHO region)?
- The highest recorded value was 78.0% in 2024.
- What is the lowest previously treated cases tested for rr-/mdr-tb recorded in Americas (WHO region)?
- The lowest recorded value was 11.0% in 2006.
- How does Americas (WHO region) rank for previously treated cases tested for rr-/mdr-tb?
- Americas (WHO region) ranks 8th out of 11 groups with data for 2024.
- Is previously treated cases tested for rr-/mdr-tb rising or falling in Americas (WHO region)?
- Over the last ten years it is up 136.4%. The long-run trend across the full record is volatile.
- Where does this Americas (WHO region) data come from?
- The figures come from World Health Organization, Global Health Observatory, published as part of Previously treated cases tested for RR-/MDR-TB (%). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 20 observations, free to reuse under CC BY-NC-SA 3.0 IGO (WHO).